Equity lens criteria | What evidence for the criteria to look for in clinical guidelines |
---|---|
1. Do the public health recommendations in the guidelines address a priority problem for disadvantaged populations? | Discussions on the burden of disease in disadvantaged populations. |
2. Is there a reason to anticipate different effects of intervention in disadvantaged and privileged populations? | Discussions on differences between disadvantaged and privileged populations, in terms of biology of the disease, adherence, and baseline risks. |
3. Are the effects of the intervention valued differently by disadvantaged compared to privileged populations? | Values may be assessed in guideline development panels through consultations with disadvantaged populations, involvement of their caregivers, reference to relevant research, or transparent reflection. |
4. Is specific attention given to minimizing barriers to implementation in disadvantaged populations? | Discussion of barriers to implementation in disadvantaged populations and identification of strategies to overcome these barriers. |
5. Do plans for assessing the impact of the recommendations include disadvantaged populations? | Plans for monitoring disadvantaged groups according to place of residence, race, occupation, gender, religion, education, socioeconomic status, or social network and capital. |